Lip fillers gone wrong or normal side effect? Expert breaks down Uorfi Javed's swollen lips
Uorfi Javed, the popular Indian television star known for her unapologetically bold looks, recently sparked concern after posting selfies showing extremely swollen lips. But contrary to public assumption that she got new fillers, the reality is different, Uorfi had gone to dissolve her previous fillers, not enhance them.
So what caused the exaggerated puffiness? We got Dr Ameesha Mahajan, Cosmetic Dermatologist & Founder, Eden Skin Clinic to dig into the matter and explain what might have actually happend with Uorfi!
What exactly happened?
On July 20, 2025, Uorfi posted selfies and a video with visibly swollen, pouty lips, prompting a wave of concern and speculation. Many assumed she had undergone a fresh filler procedure. However, she later clarified that she had actually gone to dissolve her previous lip fillers.
But what was supposed to reduce volume led to sudden, dramatic swelling instead.
View this post on Instagram
A post shared by ColorsTV (@colorstv)
What causes this kind of swelling after dissolving fillers?
During the process of dissolving fillers, an enzyme called hyaluronidase is injected to break down the hyaluronic acid used in the lip fillers. Usually, it is safe and effective to use but every body is different and it still requires a patch test before administration. In the absence of patch tests and the body not accepting hyaluronidase, serious swelling can occur, especially in the areas as sensitive as the lips.
According to dermatologists:
The injection itself causes trauma, leading to mild swelling.
In some cases, hyaluronidase can cause allergic or inflammatory reactions.
The volume of fluid injected during the process can cause lips to look more swollen for 24–72 hours in certain cases. In most cases, you will notice an immediate resolution.
Is this normal or a complication?
Experts say mild to moderate swelling post-dissolving is common, especially in lips which are vascular and sensitive. However -
If the swelling is severe, one-sided, painful, or red, it might indicate a reaction or infection.
Very rarely, but yes, hyaluronidase can cause allergic responses, especially if a patch test wasn't done prior.
These side effects are temporary but should be monitored by a medical professional.
Uorfi's case – cause for concern or expected reaction?
In Uorfi's case, while the swelling looked dramatic, she did not report any signs of pain, fever, or skin discoloration—all of which would indicate a more serious issue. Experts believe that the appearance of her lips suggest that her body reacted to hyaluronidase and it is probable that there was no patch test conducted prior to administering this enzyme.
Important tips if you're considering filler dissolving treatments
Always visit a qualified dermatologist or plastic surgeon for both fillers and dissolving procedures.
Request a patch test before using hyaluronidase, especially if it's your first time.
Expect swelling for 24–72 hours after dissolving—don't panic unless symptoms worsen.
Report immediately if you feel pain, have redness, fever, or uneven swelling.
Aftercare matters—ice application, avoiding pressure, and keeping the area clean can help.
Experts are of the opinion that Uorfi Javed's swollen lips could be attributed to an absence of patch test prior to filler resolving and a reaction-triggered by hyaluronidase. Though temporary swelling is common post filler resolving, what we see here is something more serious than that.
If you're planning to get fillers dissolved, don't get alarmed. Work with a skilled expert, understand the healing timeline, and stay alert to warning signs. In the right hands, even reversal is safe and manageable.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
4 hours ago
- Time of India
ICT Mumbai biocluster receives catalytic funding to boost translational biopharma research
Mumbai: In a significant boost to India's translational research ecosystem, ICT Mumbai's Biocluster secured Rs 30 crore in catalytic funding from the Indian Translational Research Institute (ITRI). The translational biopharmaceutical facility aims to bridge the gap between lab-stage research and clinical application. The eight-storey cluster will focus on rare diseases, synthetic biology, and AI-driven drug development. It will house a GMP-ready biologics pilot plant, shared R&D infrastructure, and advanced training zones for workforce development. Dr Ratnesh Jain, Principal Investigator of the project, said the Biocluster aims to make Indian biopharma globally competitive. ITRI CEO Dr Abdur Rub emphasised the need to de-risk innovation and scale healthcare solutions. Positioned as a national translational platform, the Mumbai Biocluster seeks to empower startups, academia, and industry alike—enabling faster, capital-efficient transitions from research to real-world impact. You Can Also Check: Mumbai AQI | Weather in Mumbai | Bank Holidays in Mumbai | Public Holidays in Mumbai
Time of India
4 hours ago
- Time of India
Ayurvedic doctor shares what a proper healthy day looks like and what should NOT be done
Let's be honest, life's hectic these days. Most of us barely stop to breathe, let alone think about our daily routines. But funny enough, it's often the small, steady habits that keep us sane. Ayurveda! The old Indian system of health has a few ideas about how to live better. And no, it's not just about herbs and oils. A lot of it is about timing up your daily life with the body's own natural rhythm. They've got a word for it: Dinacharya . It basically means 'daily routine'. Nothing too wild. Just doing things at the right time. Sounds obvious, but it's easy to forget. Starting with the mornings. There's this window, from like 3 AM to 7:30 AM, that's supposed to be ideal for getting up and going. Apparently the first half is ruled by something called Vata, which makes it easier to wake up with a clear head. Once the sun's up, Kapha kicks in, and that's when things feel heavier. So, getting out of bed earlier kind of gives you a head start. What do you do after waking? Well, scrape your tongue, swish a bit of oil around your mouth (oil pulling, they call it), and drink some copper-vessel water if you have one lying around. Sounds odd, but these old tricks are supposed to help get your digestion moving. A bit of stretching or yoga? That's next. Nothing fancy. Maybe 10–15 minutes tops. Throw in some deep breathing or sit quietly. Keeps the stress down and helps your body do its thing. Hormones stay balanced. People feel better. Image : Canva Breakfast? Keep it simple. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Remember Him? Take A Deep Breath Before You See Him Now The Noodle Box Undo Soaked almonds or dates are good. Even some roasted mung bean flour mixed with buttermilk (or lassi) is filling but not heavy. You want fuel, not a food coma. Midday is when your digestion's at its strongest. Around 12 to 1 PM. So, that's when to eat your biggest meal. If you're gonna have something rich or protein-heavy, this is the time. Your body can actually handle it now. By late afternoon, around 3 or 4 PM, you'll probably want a light snack. Nothing big. A piece of fruit or two. Just enough to stop you from crashing. Evenings around 5 to 7 PM is the good time to move. Whether that's a jog, the gym, or just a walk, this is when your muscles are ready to go. After that, slow things down. From 7 PM onwards, you should start switching off. Not saying you need to sit in silence, but maybe ditch the emails. Listen to music. Talk to someone. Do some candle gazing (Trataka), if that's your thing. Light dinner too. Vegetarian's best. Don't eat too late, it messes with your sleep and digestion. Now, this part matters: 10 PM to 2 AM is when your body does the heavy lifting, repairing, restoring, regenerating. If you're still awake scrolling Instagram, you're messing with that process. Try to be asleep by 10. Keep the room dark. Skip the screens. Let your brain and body rest properly. In the end, it's not about being perfect. Ayurveda just gives you a bit of a roadmap. Not a rulebook. Even if you follow a few of these suggestions, wake up earlier, eat when your digestion's strong, sleep on time, you'll likely feel better. (By Dr Somit Kumar, M.D (Ayu), PhD, Chief Scientific Officer & Director of Research, AVP Research Foundation)
Time of India
4 hours ago
- Time of India
Cheaper cancer care therapy earns big bucks for pharma company
ImmunoAct, an Indian cell and gene therapy company, has achieved profitability in its first full year, generating ₹62 crore in revenue and ₹12 crore in profit before tax in FY25. Its NexCAR19, an affordable CAR-T therapy, has been administered to over 350 patients across India. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads India's cell and gene therapy pioneer ImmunoAct has turned profitable in its first full year of operations, a rare feat in the country's emerging startup landscape where research-based pharma enterprises encounter serious scale and cash flow in which Hyderabad-based drugmaker Laurus Labs has roughly 34% equity stake, saw revenues of ₹62 crore with a profit before tax of ₹12 crore in FY25, according to sources. The year before, ImmunoAct had revenues of ₹11 by immunologist Rahul Purwar in 2013, ImmunoACT was spun off from the department of bioengineering department of IIT Bombay in NexCAR19 is the first indigenously developed breakthrough cancer CAR-T (chimeric antigen receptor T-cell) therapy approved by India's central drug regulatory agency in October was formally launched in India in April 2024 at a price ~90% cheaper than its US and European counterparts like Novartis and Gilead, making it far more affordable for India and low-and-middle income countries, on its potential approval. So far, the therapy has been infused in over 350 patients across 70 hospitals in CAR-T treatment, the patient's immune cells are extracted and through a maze of re-engineering processes infused back to recognize and kill cancer cells, giving a longer remission to patients as compared to the conventional options like immunotherapy or bone marrow transplants. The therapy is used when all other options are CAR-T dose (one-and-done infusion) costs around ₹30 lakh, which was initially priced at ₹42 lakh, and is expected to see a further decline as demand picks ImmunoACT has recently appointed former managing director of Roche India V Simpson Immanuel as its strategic Purwar added, "We needed someone who understands not just the commercial landscape, but also the nuances of innovation, patient access, and global expansion."Earlier this year, Immuneel Therapeutics, backed by leading names like Kiran Mazumdar-Shaw and globally renowned oncologist Siddhartha Mukherjee secured approval for Qartemi, its cell therapy for adult B-cell non-Hodgkin Lymphoma, in India. Companies like Cipla , Dr Reddy's Labs and Bharat Biotech are investing heavily in new CAR-Ts are at the frontiers of a range of cancer treatments, attracting billions of dollars in investments from large drugmakers. The market for such therapies is expected to touch $134 billion by 2034 from around $10 billion at present.
